Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;38(4):759-769.
doi: 10.1007/s10554-021-02461-3. Epub 2021 Nov 10.

Using deep learning method to identify left ventricular hypertrophy on echocardiography

Affiliations

Using deep learning method to identify left ventricular hypertrophy on echocardiography

Xiang Yu et al. Int J Cardiovasc Imaging. 2022 Apr.

Abstract

Background: Left ventricular hypertrophy (LVH) is an independent prognostic factor for cardiovascular events and it can be detected by echocardiography in the early stage. In this study, we aim to develop a semi-automatic diagnostic network based on deep learning algorithms to detect LVH.

Methods: We retrospectively collected 1610 transthoracic echocardiograms, included 724 patients [189 hypertensive heart disease (HHD), 218 hypertrophic cardiomyopathy (HCM), and 58 cardiac amyloidosis (CA), along with 259 controls]. The diagnosis of LVH was defined by two experienced clinicians. For the deep learning architecture, we introduced ResNet and U-net++ to complete classification and segmentation tasks respectively. The models were trained and validated independently. Then, we connected the best-performing models to form the final framework and tested its capabilities.

Results: In terms of individual networks, the view classification model produced AUC = 1.0. The AUC of the LVH detection model was 0.98 (95% CI 0.94-0.99), with corresponding sensitivity and specificity of 94.0% (95% CI 85.3-98.7%) and 91.6% (95% CI 84.6-96.1%) respectively. For etiology identification, the independent model yielded good results with AUC = 0.90 (95% CI 0.82-0.95) for HCM, AUC = 0.94 (95% CI 0.88-0.98) for CA, and AUC = 0.88 (95% CI 0.80-0.93) for HHD. Finally, our final integrated framework automatically classified four conditions (Normal, HCM, CA, and HHD), which achieved an average of AUC 0.91, with an average sensitivity and specificity of 83.7% and 90.0%.

Conclusion: Deep learning architecture has the ability to detect LVH and even distinguish the latent etiology of LVH.

Keywords: Deep learning; Echocardiography; Left ventricular hypertrophy.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that they have no conflict of interest.

Figures

Fig.1
Fig.1
The architecture of the integrated framework. aLeft ventricular hypertrophy, bhypertrophic cardiomyopathy, ccardiac amyloidosis dhypertensive heart disease
Fig. 2
Fig. 2
Basic architecture of LVH detection and etiology classification models. This figure shows the inner architecture of the green block in the Fig. 1. aparasternal long-axis, bapical four-chamber
Fig. 3
Fig. 3
The results of individual classification network. LVH left ventricular hypertrophy, HCM hypertrophic cardiomyopathy, CA cardiac amyloidosis, HHD hypertensive heart disease
Fig. 4
Fig. 4
The masks created by manual annotation and auto-segmentation, and the newly generated images of left ventricular myocardium. acardiac amyloidosis, bhypertrophic cardiomyopathy, chypertensive heart disease
Fig. 5
Fig. 5
The results of classification networks on automatically or manually segmented images. LVH left ventricular hypertrophy, HCM hypertrophic cardiomyopathy, CA cardiac amyloidosis, HHD hypertensive heart disease
Fig. 6
Fig. 6
The results of the final integrated framework. HCM hypertrophic cardiomyopathy, CA cardiac amyloidosis, HHD hypertensive heart disease
Fig. 7
Fig. 7
Class activation maps. The heatmaps created by Grad-CAM method highlight the regions which mainly influence the decisions made by the network

References

    1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–1566. doi: 10.1056/NEJM199005313222203. - DOI - PubMed
    1. Stewart MH, Lavie CJ, Shah S, Englert J, Gilliland Y, Qamruddin S, et al. Prognostic implications of left ventricular hypertrophy. Prog Cardiovasc Dis. 2018;61:446–455. doi: 10.1016/j.pcad.2018.11.002. - DOI - PubMed
    1. Suneja G, Viswanathan A. Gynecologic malignancies. Hematol Oncol Clin N Am. 2020;34:71–89. doi: 10.1016/j.hoc.2019.08.018. - DOI - PubMed
    1. Perlini S, Mussinelli R, Salinaro F. New and evolving concepts regarding the prognosis and treatment of cardiac amyloidosis. Curr Heart Fail Rep. 2016;13:267–272. doi: 10.1007/s11897-016-0311-y. - DOI - PubMed
    1. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:e50–103. doi: 10.1016/j.jacc.2010.09.001. - DOI - PubMed

LinkOut - more resources